A fast-growing drug manufacturer with 1,000 workers and locations in Research Triangle Park and Wilmington has been scooped up by private equity firms, including one led by former Quintiles executives.
A fast-growing drug manufacturer with 1,000 workers and locations in Research Triangle Park and Wilmington has been scooped up by private equity firms, including one led by former Quintiles executives.
